Aardvark Therapeutics, Inc. Common Stock (AARD)
NASDAQ·Healthcare·Biotechnology
$5.69
+10.58%
Mkt Cap $138.31M
Analyst Ratings
Buy
2
Hold
2
Sell
1
Price Target (7 analysts)
$4.50
Range $3.00 – $6.00
Implied Upside
-21.0%
Consensus $4.50 vs current $5.69